Healthcare, R&D IT Conference

The accessibility and availability of managed healthcare information and data originating from claims clearinghouses, electronic transaction companies, and electronic medical records (EMR)/electronic healthcare records (EHR) vendors are creating new opportunities to optimize the drug development process. The emerging role of these data sources in clinical research processes will be the focus of the upcoming Drug Information Association's (DIA; Horsham, PA, USA) Research and Development (R&D) Meets Healthcare Information Technology (HIT) conference, March 26-29, 2006, in Philadelphia (PA, USA).

R&D Meets Healthcare IT will provide clinical researchers with the latest information on using emerging databases for site and patient recruitment, obtaining reliable data from claims clearinghouses and EMR/HER vendors, and other pertinent topics from leaders in the private and public sectors as well as from the U.S Food and Drug Administration (FDA). In his keynote address, Dr. Scott Gottlieb, the FDA deputy commissioner for medical and scientific affairs, will discuss the potential of EMR/HER to transform healthcare ad public health initiatives.

This conference is co-sponsored by the Healthcare Information and Management Systems Society (HIMSS; Chicago, IL, USA), and will be held concurrently with DIA's 21st Annual Clinical Data Management Symposium and Exhibition, allowing participants to attend numerous lectures and discussions and examine an expanded exhibit space.

The Drug Information Association serves professionals in the biotechnology, pharmaceutical, and regulatory industries worldwide. Through its U.S. and international meetings, training courses, workshops, and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes.



Related Links:
Drug Information Association